Acute Ketamine Infusion in Rat Does Not Affect In Vivo [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5
暂无分享,去创建一个
[1] J. Démonet,et al. Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience , 2019, Front. Med..
[2] K. Behar,et al. Glutaminase activity in GLS1 Het mouse brain compared to putative pharmacological inhibition by ebselen using ex vivo MRS , 2019, Neurochemistry International.
[3] S. Mingote,et al. Molecular Imaging of mGluR5 Availability with [11C]ABP68 in Glutaminase Heterozygous Mice , 2018, Cellular and Molecular Neurobiology.
[4] Yiyun Huang,et al. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] Steven Staelens,et al. Fast and Accurate Rat Head Motion Tracking With Point Sources for Awake Brain PET , 2017, IEEE Transactions on Medical Imaging.
[6] R. Parsey,et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression , 2017, Molecular Psychiatry.
[7] Steven Staelens,et al. Markerless rat head motion tracking using structured light for brain PET imaging of unrestrained awake small animals , 2017, Physics in medicine and biology.
[8] K. Wernecke,et al. Influence of Volatile Anesthesia on the Release of Glutamate and other Amino Acids in the Nucleus Accumbens in a Rat Model of Alcohol Withdrawal: A Pilot Study , 2017, PloS one.
[9] A. Bauer,et al. Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain , 2016, Journal of sleep research.
[10] Phillip E. Vlisides,et al. Ketamine: 50 Years of Modulating the Mind , 2016, Front. Hum. Neurosci..
[11] J. Mann,et al. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [11C]ABP688 , 2015, Translational Psychiatry.
[12] R. Parsey,et al. In Vivo Ketamine-Induced Changes in [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5 , 2015, Biological Psychiatry.
[13] V. Treyer,et al. Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. , 2014, The international journal of neuropsychopharmacology.
[14] Steven Staelens,et al. The [18F]FDG μPET Readout of a Brain Activation Model to Evaluate the Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator JNJ-42153605 , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[15] Mark E. Schmidt,et al. N-Acetylcysteine– and MK-801–Induced Changes in Glutamate Levels Do Not Affect In Vivo Binding of Metabotropic Glutamate 5 Receptor Radioligand 11C-ABP688 in Rat Brain , 2013, The Journal of Nuclear Medicine.
[16] Yiyun Huang,et al. Awake Nonhuman Primate Brain PET Imaging with Minimal Head Restraint: Evaluation of GABAA-Benzodiazepine Binding with 11C-Flumazenil in Awake and Anesthetized Animals , 2013, The Journal of Nuclear Medicine.
[17] Yiyun Huang,et al. Studies of the metabotropic glutamate receptor 5 radioligand [11C]ABP688 with N‐acetylcysteine challenge in rhesus monkeys , 2013, Synapse.
[18] H. William Strauss,et al. Recent Advances in the Molecular Imaging of Programmed Cell Death: Part II—Non–Probe-Based MRI, Ultrasound, and Optical Clinical Imaging Techniques , 2013, The Journal of Nuclear Medicine.
[19] A. Aliaga,et al. Test‐retest stability of cerebral mGluR5 quantification using [11C]ABP688 and positron emission tomography in rats , 2012, Synapse.
[20] X. Langlois,et al. Patterns of Brain Glucose Metabolism Induced by Phosphodiesterase 10A Inhibitors in the Mouse: A Potential Translational Biomarker , 2011, Journal of Pharmacology and Experimental Therapeutics.
[21] Gregor Hasler,et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. , 2011, The American journal of psychiatry.
[22] X. Langlois,et al. Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist , 2011, Psychopharmacology.
[23] Christine DeLorenzo,et al. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[24] T. Patterson,et al. Potential neurotoxicity of ketamine in the developing rat brain. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[25] H. Hemmings,et al. Volatile Anesthetic Effects on Glutamate versus GABA Release from Isolated Rat Cortical Nerve Terminals: Basal Release , 2006, Journal of Pharmacology and Experimental Therapeutics.
[26] Simon R. Cherry,et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain , 2003, NeuroImage.
[27] H. Hemmings,et al. Effects of Isoflurane and Propofol on Glutamate and GABA Transporters in Isolated Cortical Nerve Terminals , 2003, Anesthesiology.
[28] Jeffrey A Lieberman,et al. Effects of Ketamine, MK-801, and Amphetamine on Regional Brain 2-Deoxyglucose Uptake in Freely Moving Mice , 2000, Neuropsychopharmacology.
[29] R. Mailman,et al. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation , 1998, Brain Research.
[30] Bita Moghaddam,et al. Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.
[31] A. Young,et al. Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 , 1995, Neuropharmacology.
[32] I. Langmoen,et al. The effect of the volatile anesthetic isoflurane on Ca2+-dependent glutamate release from rat cerebral cortex , 1994, Brain Research.
[33] M. Cohen,et al. Distribution in the Brain and Metabolism of Ketamine in the Rat after Intravenous Administration , 1973, Anesthesiology.
[34] M Slifstein,et al. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery , 2014, Molecular Psychiatry.
[35] J. Clements,et al. Pharmacokinetics and analgesic effect of ketamine in man. , 1981, British journal of anaesthesia.